MDT - DexCom Insulet Tandem seen benefitting the most in diabetes survey - Wells Fargo
2024-04-29 09:24:45 ET
More on DexCom, Insulet, Tandem
- DexCom, Inc. (DXCM) Q1 2024 Earnings Call Transcript
- DexCom, Inc. 2024 Q1 - Results - Earnings Call Presentation
- DexCom Is Pricey For A Reason - Its Growth Story Reflects That
- Dexcom down 7% after hours despite quarterly beats, 2024 outlook updates
- DexCom Non-GAAP EPS of $0.32 beats by $0.05, revenue of $921M beats by $10.1M